Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis

Nature Cell Biology

Volumn 17, Issue 3, 2015, Pages 311-321

  Shoshan, Einav ^a   Mobley, Aaron K ^a   Braeuer, Russell R ^a   Kamiya, Takafumi ^a   Huang, Li ^a   Vasquez, Mayra E ^a   Salameh, Ahmad ^b   Lee, Ho Jeong ^a   Kim, Sun Jin ^a   Ivan, Cristina ^b   Velazquez Torres, Guermarie ^a   Nip, Ka Ming ^c   Zhu, Kelsey ^c   Brooks, Denise ^c   Jones, Steven J M ^c   Birol, Inanc ^c   Mosqueda, Maribel ^b   Wen, Yu Ye ^b   Eterovic, Agda Karina ^b   Sood, Anil K ^a,b   Hwu, Patrick ^b   Gershenwald, Jeffrey E ^a   Gordon Robertson, A ^a   Calin, George A ^b   Markel, Gal ^d,e   Fidler, Isaiah J ^a   Bar Eli, Menashe ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c CANADA'S MICHAEL SMITH GENOME SCIENCES CENTRE   (Canada)

^d SHEBA MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INOSINE; MICRORNA; MICRORNA 455 5P; UNCLASSIFIED DRUG; ADAR1 PROTEIN, HUMAN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CPEB1 PROTEIN, HUMAN; CREB1 PROTEIN, HUMAN; LUCIFERASE; MIRN455 MICRORNA, HUMAN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPEB1 GENE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL LINE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA EDITING; RNA SEQUENCE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILD TYPE; ANIMAL; CANCER TRANSPLANTATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUDE MOUSE; PATHOLOGY; REPORTER GENE; SKIN TUMOR; TUMOR CELL LINE;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; INOSINE; LUCIFERASES; MELANOMA; MICE; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RNA EDITING; RNA-BINDING PROTEINS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84923850254     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3110     Document Type: Article

References (38)

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin. 64, 9-29 (2014
2. Miller, A. J. & Mihm, M. C. Jr Melanoma. N. Engl. J. Med. 355, 51-65 (2006
3. Xie, S., et al. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene 15, 2069-2075 (1997
4. Mobley, A. K., Braeuer, R. R., Kamiya, T., Shoshan, E. & Bar-Eli, M. Driving transcriptional regulators in melanoma metastasis. Cancer Metastasis Rev. 31, 621-632 (2012
5. Jean, D., Harbison, M., McConkey, D. J., Ronai, Z. & Bar-Eli, M. CREB and its associated proteins act as survival factors for human melanoma cells. J. Biol. Chem. 273, 24884-24890 (1998
6. Melnikova, V. O. & Bar-Eli, M. Transcriptional control of the melanoma malignant phenotype. Cancer Biol. Ther. 7, 997-1003 (2008
7. Melnikova, V. O., Mourad-Zeidan, A. A., Lev, D. C. & Bar-Eli, M. Platelet-Activating factor mediates MMP-2 expression and activation via phosphorylation of cAMPresponse element-binding protein and contributes to melanoma metastasis. J. Biol. Chem. 281, 2911-2922 (2006
8. Dobroff, A. S., et al. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. J. Biol. Chem. 284, 26194-26206 (2009
9. Bertolotto, C., et al. Microphthalmia gene product as a signal transducer in cAMPinduced differentiation of melanocytes. J. Cell Biol. 142, 827-835 (1998
10. Melnikova, V. O., et al. CREB inhibits AP-2- expression to regulate the malignant phenotype of melanoma. PLoS ONE 5, e12452 (2010
11. Venables, J. P. Unbalanced alternative splicing and its significance in cancer. Bioessays 28, 378-386 (2006
12. David, C. J. & Manley, J. L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343-2364 (2010
13. Gallo, A. & Galardi, S. A-To-I RNA editing and cancer: from pathology to basic science. RNA Biol. 5, 135-139 (2008
14. Levanon, E. Y., et al. Systematic identification of abundant A-To-I editing sites in the human transcriptome. Nat. Biotechnol. 22, 1001-1005 (2004
15. Laurencikiene, J., Kallman, A. M., Fong, N., Bentley, D. L. & Ohman, M. RNA editing and alternative splicing: the importance of co-Transcriptional coordination. EMBO Rep. 7, 303-307 (2006
16. Jin, Y., Zhang, W. & Li, Q. Origins and evolution of ADAR-mediated RNA editing. IUBMB Life 61, 572-578 (2009
17. Bass, B. L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71, 817-846 (2002
18. Keegan, L. P., Gallo, A. & O'Connell, M. A. The many roles of an RNA editor. Nat. Rev. Genet. 2, 869-878 (2001
19. Maas, S., Rich, A. & Nishikura, K. A-To-I RNA editing: recent news and residual mysteries. J. Biol. Chem. 278, 1391-1394 (2003
20. Hood, J. L. & Emeson, R. B. Editing of neurotransmitter receptor and ion channel RNAs in the nervous system. Curr. Top. Microbiol. Immunol. 353, 61-90 (2012
21. Wulff, B. E. & Nishikura, K. Modulation of microRNA expression and function by ADARs. Curr. Top. Microbiol. Immunol. 353, 91-109 (2012
22. Zinshteyn, B. & Nishikura, K. Adenosine-To-inosine RNA editing. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 202-209 (2009
23. Heale, B. S., et al. Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J. 28, 3145-3156 (2009
24. Nemlich, Y., et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J. Clin. Invest. 123, 2703-2718 (2013
25. Alon, S., et al. Systematic identification of edited microRNAs in the human brain. Genome Res. 22, 1533-1540 (2012
26. Si, K., et al. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-Term facilitation in aplysia. Cell 115, 893-904 (2003
27. Sasayama, T., et al Over-expression of Aurora-A targets cytoplasmic polyadenylation element binding protein and promotes mRNA polyadenylation of Cdk1 and cyclin B1. Genes Cells 10, 627-638 (2005
28. Kawahara, Y., Zinshteyn, B., Chendrimada, T. P., Shiekhattar, R. & Nishikura, K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 8, 763-769 (2007
29. Ota, H., et al. ADAR1 forms a complex with Dicer to promote MicroRNA processing and RNA-induced gene silencing. Cell 153, 575-589 (2013
30. Yang, W., et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13, 13-21 (2006
31. Caldeira, J., et al. CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach. Gut 61, 1115-1123 (2012
32. Zhang, J H., et al. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73. Cell Death Differ. 17, 1551-1565 (2010
33. Levanon, E. Y., et al. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res. 33, 1162-1168 (2005
34. Galeano, F., et al. Human BLCAP transcript: new editing events in normal and cancerous tissues. Int. J. Cancer 127, 127-137 (2010
35. Gommans, W. M., McCane, J., Nacarelli, G. S. & Maas, S. A mammalian reporter system for fast and quantitative detection of intracellular A-To-I RNA editing levels. Anal. Biochem. 399, 230-236 (2010
36. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009
37. Landen, C. N. Jr, et al. Therapeutic EphA2 gene targeting using neutral liposomal small interfering RNA delivery. Cancer Res. 65, 6910-6918 (2005
38. Villares, G. J., et al. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-Activated receptor-1 small interfering RNA. Cancer Res. 68, 9078-9086 (2008